On September 12th, Tencent Holdings and Meituan-Dianping have both announced share repurchase plans. Tencent Holdings plans to repurchase shares at a cost of 1.001 billion Hong Kong dollars.
According to the disclosure documents of hkex on September 13, Tencent (00700.HK), Meituan-W (03690.HK), and other companies repurchased shares.① Tencent (00700.HK) repurchased 2.68 million ordinary shares on September 12, involving an amount of 1.001 billion Hong Kong dollars, with a repurchase price per share ranging from 376.6 Hong Kong dollars to 371 Hong Kong dollars. Since the authorization resolution was passed, the cumulative number of repurchased securities is 0.152 billion shares, accounting for 1.618% of the number of issued shares at the time of the ordinary resolution. ② Meituan-W (03690.HK) repurchased on September
Wuxi Bio announced on September 12th that it will spend approximately 55,999.2 million Hong Kong dollars to repurchase 4.805 million shares.
Wuxi Bio (02269) issued an announcement to repurchase approximately 55.9992 million Hong Kong dollars of shares on September 12, 2024, repurchasing 4.805 million shares at a repurchase price of 11.6-11.68 Hong Kong dollars per share.
Express News | The CXO sector collectively rose, with Citigroup claiming that the stock prices of Wuxi Apptec and Wuxi Bio are undervalued.
Hong Kong stock market fluctuations | CXO concept stocks continue to rise in early trading. The Biosecurity Law is still waiting for the Senate to vote. Citigroup said that the stock price of the Chinese pharmaceutical company has been undervalued.
CXO concept stocks continued to rise in the morning session. As of the time of writing, Wuxi Bio (02269) rose 4.6% to HK$11.82; Wuxi Apptec (02359) rose 4.51% to HK$35.95; Pharmaron (03759) rose 3.84% to HK$9.73; Asymchem Laboratories (06821) rose 3.84% to HK$41.95.
on September 11th, Tencent Holdings and Meituan-W and others have made buybacks, with Tencent Holdings spending 1.001 billion Hong Kong dollars
According to the disclosure documents of hkex on September 12th, Tencent Holdings (00700.HK), Meituan-W (03690.HK), and other companies repurchased shares. ① Tencent Holdings (00700.HK) repurchased 2.72 million ordinary shares on September 11th, involving an amount of 1.001 billion Hong Kong dollars, with a repurchase price ranging from 370.6 Hong Kong dollars to 365.2 Hong Kong dollars per share. Since the authorization resolution for repurchase, the cumulative number of repurchased securities is 0.15 billion shares, accounting for 1.589% of the number of issued shares at the time of the ordinary resolution. ② Meituan-W (03690.HK) on
wuxi bio spent 59.893 million Hong Kong dollars on September 11 to repurchase 5.38 million shares.
On September 11th, Wuxi Bio (02269.HK) announced that it repurchased 5.38 million shares at a cost of 59.893 million Hong Kong dollars.